The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats
AMA 10th edition
In-text citation: (1), (2), (3), etc.
Reference: Dewi NA, Hapsari D, Refa S, Sujuti H. The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats. Eurasia J Biosci. 2019;13(2), 887-891.

APA 6th edition
In-text citation: (Dewi et al., 2019)
Reference: Dewi, N. A., Hapsari, D., Refa, S., & Sujuti, H. (2019). The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats. Eurasian Journal of Biosciences, 13(2), 887-891.

Chicago
In-text citation: (Dewi et al., 2019)
Reference: Dewi, Nadia Artha, Dian Hapsari, Safaruddin Refa, and Hidayat Sujuti. "The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats". Eurasian Journal of Biosciences 2019 13 no. 2 (2019): 887-891.

Harvard
In-text citation: (Dewi et al., 2019)
Reference: Dewi, N. A., Hapsari, D., Refa, S., and Sujuti, H. (2019). The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats. Eurasian Journal of Biosciences, 13(2), pp. 887-891.

MLA
In-text citation: (Dewi et al., 2019)
Reference: Dewi, Nadia Artha et al. "The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats". Eurasian Journal of Biosciences, vol. 13, no. 2, 2019, pp. 887-891.

Vancouver
In-text citation: (1), (2), (3), etc.
Reference: Dewi NA, Hapsari D, Refa S, Sujuti H. The role of an angiopoietin-2 inhibitor in decreasing pericyte loss in diabetic rats. Eurasia J Biosci. 2019;13(2):887-91.

Abstract

Background: The ratio of pericytes:endothelial cells in normal retinal vasculature is 1:1. Pericyte loss is the earliest morphological change in the diabetic retina and predominant characteristic in diabetic retinopathy. Diabetic retinopathy is associated with angiopoietin 2 (Ang-2). The aim of this study is to determine the role of an Ang-2 inhibitor in decreasing pericyte loss in diabetic rats.
Material and Methods: True experimental using rat model. Diabetic rats induced by intraperitoneal injection of streptozotocin (STZ). The samples were divided into 5 groups, injected intravitreally with vehicle (DMSO) or Ang-2 inhibitor with variation dose (10,20, and 30 μg). After one month the rat eyes were enucleated. Retinal digest preparation and HE staining was done to examine the retinal vasculature and count pericyte : endothel ratio.
Results: The number of pericytes reduced by 40% (1:2.5) after five weeks of diabetes induction in the diabetic rat model. The group receiving 10 μg Ang-2 inhibitor showed the best results in terms of reducing pericyte loss (1:1.8).The group receiving 20 μg Ang-2 inhibitor had a pericyte:endothelial ratio of 1:2.1. The pericyte loss was not decreased in the group receiving 30 μg Ang-2 inhibitor (1:2.8). Linear regression analysis revealed that there was a positive relationship between administration of the Ang-2 inhibitor and a reduction in pericyte loss in diabetic rats (p > 0.05).
Conclusion: Intravitreal administration of an Ang-2 inhibitor, at certain doses, reduced pericyte loss in diabetic rats.

References

  • Abhary S, Burdon K, Laurie K, et al. (2010) Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care, 33: 1834-1836. https://doi.org/10.2337/dc09-1893
  • Adamis AP, Berman AJ (2008) Mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol, 30(2): 65-84. https://doi.org/10.1007/s00281-008-0111-x
  • Allt G, Lawrenson JG (2001) Pericytes: cell biology and pathology. Cells Tissues Organs, 169: 1-11. https://doi.org/10.1159/000047855
  • Bouterse SM, Kowluru RA (2008) Oxidative stress and diabetic retinopathy: Pathophysiologycal mechanisms and treatment perspectives. Rev Endocr Metab Disord, 9: 315-327. https://doi.org/10.1007/s11154-008-9090-4
  • Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications dalam. www.nature.org (online) https://doi.org/10.1038/414813a
  • Dewi NA, Dlyaul Haq NM, Sujuti H,Aulanni’am A, Soeatmadji DW (2015) Retinal Digest Procedures for Examining Pericyte and Endothelial On Retinal Vasculature Using rat Model. International Journal of ChemTech Research, 8(6): 607-11.
  • Felcth M, Luck R, Schering A, Seidel P, Srivasta K, Hu J, et al. (2012) Angiopoietin 2 differentially regulates angiogenesis thtough TIE 2 and integrin signaling. K clin Invest, 122(6): 1991-2005. https://doi.org/10.1172/JCI58832
  • Hammes H, Feng Y, Pfister F, Brownlee M (2011) Diabetic Retinopathy: Targeting Vasoregression: Hyperglycemia and the Molecular Changes in the Early Diabetic Retina. Diabetes, 60(1): 9-16. https://doi.org/10.2337/db10-0454
  • Hammes H, Lin J, Renner O, et al. (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes, 51: 3107-3112. https://doi.org/10.2337/diabetes.51.10.3107
  • Holopainen T, Sahainen P, D’amico G, et al. (2012) Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. J Natl Cancer Inst, 104: 461–475. https://doi.org/10.1093/jnci/djs009
  • Hu B, Cheng S-Y (2009) Angiopoietin-2: Development of Inhibitors for Cancer Therapy. Curr Oncol Rep; 11(2): 111–116. https://doi.org/10.1007/s11912-009-0017-3
  • Morgan CL, Owens DR, Aubonnet P, et al. (2013) Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open, 3: e004025. https://doi.org/10.1136/bmjopen-2013-004025
  • Pfister F, Feng Y, Hagen F, et al. (2008) A Novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes, 57: 2495-2502. https://doi.org/10.2337/db08-0325
  • Rangasamy S, Srinivasan P, Maestas J, McGuire PG, Das A (2011) A Potential Role for Angiopoietin 2 in the Regulation of the Blood-Retinal Barrier in Diabetic Retinopathy. iovs: 10-6386. https://doi.org/10.1167/iovs.10-6386
  • Tarr JM, Kaul K, Chopra M, Kohner E, Chibber R (2013) Pathophysiology of Diabetic Retinopathy. ISRN Opthalmology. ID 343560, 13 pages. https://doi.org/10.1155/2013/343560
  • Thomas RL, Dunstan F, Luzio SD, et al. (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ, 344: e874. https://doi.org/10.1136/bmj.e874
  • Thurston G, Daly C (2012) The complex role angiopoietin 2 in the angiopoietin-Tie signaling pathway. Cold spring harb perspect med. https://doi.org/10.1101/cshperspect.a006650
  • Willard AL, Herman IM (2012) Vascular Complications and Diabetes: Current Therapies and Future Challanges. Journal of Ophthalmology, 25: 1-14. https://doi.org/10.1155/2012/209538
  • World Health Organization (WHO) (2012) Global data on visual impairments 2010. Geneva.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.